1. Is the placement of jejunostomy tubes in patients with esophageal cancer undergoing esophagectomy associated with increased inpatient healthcare utilization? An analysis of the National Readmissions Database
- Author
-
Ernest L. Rosato, Adam C. Berger, Nathaniel R. Evans, Francesco Palazzo, Courtney L. Devin, Richard Zheng, Spencer Liem, and Arturo J. Rios-Diaz
- Subjects
Male ,Databases, Factual ,Esophageal Neoplasms ,Nutritional Supplementation ,medicine.medical_treatment ,Jejunostomy ,Malignancy ,computer.software_genre ,Patient Readmission ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,In patient ,Aged ,Chemotherapy ,Jejunostomy tubes ,Database ,business.industry ,General Medicine ,Middle Aged ,Patient Acceptance of Health Care ,Esophageal cancer ,medicine.disease ,United States ,Esophagectomy ,030220 oncology & carcinogenesis ,Propensity score matching ,Female ,030211 gastroenterology & hepatology ,Surgery ,business ,computer - Abstract
Patients undergoing esophagectomy often receive jejunostomy tubes (j-tubes) for nutritional supplementation. We hypothesized that j-tubes are associated with increased post-esophagectomy readmissions.We identified esophagectomies for malignancy with (EWJ) or without (EWOJ) j-tubes using the 2010-2015 Nationwide Readmissions Database. Outcomes include readmission, inpatient mortality, and complications. Outcomes were compared before and after propensity score matching (PSM).Of 22,429 patients undergoing esophagectomy, 16,829 (75.0%) received j-tubes. Patients were similar in age and gender but EWJ were more likely to receive chemotherapy (24.2% vs. 15.1%, p 0.01). EWJ was associated with decreased 180-day inpatient mortality (HR 0.72 [0.52-0.99]) but not with higher readmissions at 30- (15.2% vs. 14.0%, p = 0.16; HR 0.9 [0.77-1.05]) or 180 days (25.2% vs. 24.3%, p = 0.37; HR 0.94 [0.79-1.10]) or increased complications (p = 0.37). These results were confirmed in the PSM cohort.J-tubes placed in the setting of esophagectomy do not increase inpatient readmissions or mortality.
- Published
- 2021